Panel: Reimagining Healthcare by bridging the gap between Innovation and Patient Impact
June 25, 2025
Innovation Stage
- Can groundbreaking innovations in AI, multi-omics, and biodata reduce the traditional $2.5 billion, 10-year drug development process to a mere 2 years and $2 million? What tools, policies, and collaborations are required to turn this aspiration into reality?
- With accelerated drug development and cost efficiencies, can medications cost be reduced? How would such changes align with the commercial healthcare systems and the dynamics of pricing, access, and equity?
- What essential components (diverse data sets, AI-driven insights, multi-omics integration, and inclusive innovation) must be prioritized to transition from current limitations to transformative healthcare solutions? What can we learn from existing successes?
